Sven Schippling

Sven Schippling

UNVERIFIED PROFILE

Are you Sven Schippling?   Register this Author

Register author
Sven Schippling

Sven Schippling

Publications by authors named "Sven Schippling"

Are you Sven Schippling?   Register this Author

62Publications

1768Reads

31Profile Views

Correction to: Retinal pathology in experimental optic neuritis is characterized by retrograde degeneration and gliosis.

Acta Neuropathol Commun 2019 Oct 18;7(1):157. Epub 2019 Oct 18.

Neuroimmunology and Multiple Sclerosis Research, Clinic for Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40478-019-0825-0DOI Listing
October 2019

Retinal pathology in experimental optic neuritis is characterized by retrograde degeneration and gliosis.

Acta Neuropathol Commun 2019 Jul 17;7(1):116. Epub 2019 Jul 17.

Neuroimmunology and Multiple Sclerosis Research, Clinic for Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40478-019-0768-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637505PMC
July 2019

[Neurosarcoidosis remains a diagnostic chameleon : First manifestation of neurosarcoidosis as longitudinal transverse myelitis].

Nervenarzt 2019 Apr;90(4):412-414

Klinik für Innere Medizin, Spital Linth, Gasterstraße 25, 8730, Uznach, Schweiz.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00115-018-0652-8DOI Listing
April 2019

Tocilizumab treatment in severe recurrent anti-MOG-associated optic neuritis.

Neurology 2019 Apr 20;92(16):765-767. Epub 2019 Mar 20.

From Neuroimmunology and MS Research, Neurology Clinic (H.H.-K., R.M., S.S.), University Zurich, Switzerland; and Clinical Department of Neurology (M.R.), Medical University of Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000007312DOI Listing
April 2019

Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis.

J Neuroophthalmol 2019 Mar;39(1):3-7

Neuroimmunology and Multiple Sclerosis Research (IJ, JVMH, SL, RM, AL, and SS), Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Ophthalmology (JVMH, KPW, and KL), University Hospital Zurich, Zurich, Switzerland; Department of Ophthalmology (MP), Luzerner Kantonsspital, Lucerne, Switzerland; Clinical Department of Neurology (MR), Medical University of Innsbruck, Innsbruck, Austria; and Neurology Clinic (MW, KPW), University Hospital Zurich, University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00041327-900000000-9923
Publisher Site
http://dx.doi.org/10.1097/WNO.0000000000000669DOI Listing
March 2019

Optical coherence tomography as a means to characterize visual pathway involvement in multiple sclerosis.

Curr Opin Neurol 2018 10;31(5):662-668

Neuroimmunology and Multiple Sclerosis Research, Department of Neurology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0000000000000604DOI Listing
October 2018

Exploring experimental autoimmune optic neuritis using multimodal imaging.

Neuroimage 2018 07 6;175:327-339. Epub 2018 Apr 6.

Neuroimmunology and Multiple Sclerosis Research, Clinic for Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuroimage.2018.04.004DOI Listing
July 2018

Estimates of age-dependent cutoffs for pathological brain volume loss using SIENA/FSL-a longitudinal brain volumetry study in healthy adults.

Neurobiol Aging 2018 05 30;65:1-6. Epub 2017 Dec 30.

Neuroimmunology and Multiple Sclerosis Research, Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01974580173042
Publisher Site
http://dx.doi.org/10.1016/j.neurobiolaging.2017.12.024DOI Listing
May 2018

Within-patient fluctuation of brain volume estimates from short-term repeated MRI measurements using SIENA/FSL.

J Neurol 2018 May 16;265(5):1158-1165. Epub 2018 Mar 16.

Neuroimmunology and Multiple Sclerosis Research, Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00415-018-8825-8
Publisher Site
http://dx.doi.org/10.1007/s00415-018-8825-8DOI Listing
May 2018

Multicenter reliability of semiautomatic retinal layer segmentation using OCT.

Neurol Neuroimmunol Neuroinflamm 2018 May 13;5(3):e449. Epub 2018 Mar 13.

NeuroCure Clinical Research Center (T.O., F.P., A.U.B.), Charité-Universitätsmedizin Berlin, Germany; Department of Ophthalmology (G.L.T.), University Hospital Zurich, University of Zurich; Neuroimmunology and Multiple Sclerosis Research Section (S.L., S.S.), Department of Neurology, University Hospital Zurich, University of Zurich, Switzerland; Center of Neuroimmunology (I.G., P.V.), Institut d'Investigacions Biomediques August Pi Sunyer (IDIBAPS)-Hospital Clinic, Barcelona, Spain; Division of Neuroinflammation and Glial Biology (R.N., C.S., A.J.G.), Department of Neurology, University of California San Francisco; Neuro-ophthalmology Division (A.J.G.), Department of Ophthalmology, University of California, San Francisco; Multiple Sclerosis Center (L.B., A.P.), Departments of Neurology and Ophthalmology, Neuro-ophthalmology Expertise Centre, VUmc, Amsterdam and Moorfields Eye Hospital (A.P.), The National Hospital for Neurology and Neurosurgery and UCL, United Kingdom; Clinical and Experimental Multiple Sclerosis Research Center (F.P.), Department of Neurology, Charité-Universitätsmedizin Berlin; Experimental and Clinical Research Center (F.P., A.U.B.), Charité-Universitätsmedizin Berlin and Max-Delbrück Center for Molecular Medicine, Germany; Department of Methods and Experimental Psychology (I.G.), Faculty of Psychology and Education, Universidad de Deusto, Bilbao, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000449DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852947PMC
May 2018

Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue.

Neurol Neuroimmunol Neuroinflamm 2018 Jan 13;5(1):e423. Epub 2017 Dec 13.

NeuroCure Clinical Research Center (G.G., A.U.B., C.P., J.D., J.B.-S., S.K.P., F.P.), Center for Stroke Research Berlin (CSB) (S.K.P.), Experimental and Clinical Research Center (J.B.-S., F.P.), and Clinical and Experimental Multiple Sclerosis Research Center (F.P.), Department of Neurology, Charité-Universitätsmedizin Berlin, Germany; Institute of Neuroimmunology and Multiple Sclerosis (M.T., I.L., S.S.), University Medical Centre Hamburg-Eppendorf, Germany; Department of Life Sciences (Y.R., A.Z.), Ben-Gurion University, Beer-Sheva, Israel; and Max-Delbrück Center for Molecular Medicine (F.P.), Berlin, Germany. G.G. and C.P. are now with St. Joseph Krankenhaus-Berlin-Weissensee, Germany. S.S. is now with Neuroimmunology and Multiple Sclerosis Research, Department of Neurology, University Hospital Zurich and University of Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000423DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730816PMC
January 2018

Outer Retinal Dysfunction in the Absence of Structural Abnormalities in Multiple Sclerosis.

Invest Ophthalmol Vis Sci 2018 01;59(1):549-560

Department of Ophthalmology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1167/iovs.17-22821DOI Listing
January 2018

Outer Retinal Dysfunction in the Absence of Structural Abnormalities in Multiple Sclerosis.

Invest Ophthalmol Vis Sci 2018 01;59(1):549-560

Department of Ophthalmology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1167/iovs.17-22821DOI Listing
January 2018

MRI FLAIR lesion segmentation in multiple sclerosis: Does automated segmentation hold up with manual annotation?

Neuroimage Clin 2017 20;13:264-270. Epub 2016 Nov 20.

Neuroimmunology and Multiple Sclerosis Research, Department of Neurology, University Hospital Zurich and University of Zurich, Frauenklinikstrasse 26, CH-8091 Zurich, Switzerland.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22131582163022
Publisher Site
http://dx.doi.org/10.1016/j.nicl.2016.11.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175993PMC
November 2017

MRI for multiple sclerosis diagnosis and prognosis.

Authors:
Sven Schippling

Neurodegener Dis Manag 2017 11;7(6s):27-29

Neuroimmunology & Multiple Sclerosis Research, Department of Neurology, University Hospital Zurich & University of Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/nmt-2017-0038DOI Listing
November 2017

Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis.

Lancet Neurol 2017 10 12;16(10):797-812. Epub 2017 Sep 12.

Department of Neurology, Amsterdam Neuroscience, VUmc MS Center Amsterdam and Dutch Expertise Centre for Neuro-ophthalmology, VU University Medical Center, Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14744422173027
Publisher Site
http://dx.doi.org/10.1016/S1474-4422(17)30278-8DOI Listing
October 2017

Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy.

Neurology 2017 Sep 23;89(11):1107-1116. Epub 2017 Aug 23.

From the Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Neuroimmunology and Multiple Sclerosis Research (S.S.), Department of Neurology, University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Department of Clinical Neurosciences (D.A.S.C., A.J.C.), University of Cambridge, UK; Sanofi (D.H.M., K.T., C.E.R., D.J., M.A.P.), Cambridge, MA; Evidence Scientific Solutions (R.J.H.), Sydney, NSW, Australia; and Evidence Scientific Solutions (P.X.), Philadelphia, PA. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004313DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595278PMC
September 2017

Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings.

Neurology 2017 Sep 23;89(11):1117-1126. Epub 2017 Aug 23.

From the Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General Hospital in Prague, Czech Republic; Neuroimmunology and Multiple Sclerosis Research, Department of Neurology (S.S.), University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Sanofi (D.H.M., K.T., M.C.C., D.J., M.A.P.), Cambridge, MA; Envision Scientific Solutions (P.X.), Philadelphia, PA; Envision Scientific Solutions (R.J.H.), Sydney, NSW, Australia; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004354DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595276PMC
September 2017

Global and regional annual brain volume loss rates in physiological aging.

J Neurol 2017 Mar 4;264(3):520-528. Epub 2017 Jan 4.

Neuroimmunology and Multiple Sclerosis Research, Department of Neurology, University Hospital Zurich and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-016-8374-yDOI Listing
March 2017

Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.

Int J Mol Sci 2016 Nov 15;17(11). Epub 2016 Nov 15.

Neuroimmunology and Multiple Sclerosis Research, Department of Neurology, University Hospital Zürich and University of Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://www.mdpi.com/1422-0067/17/11/1894
Publisher Site
http://dx.doi.org/10.3390/ijms17111894DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133893PMC
November 2016

Restoring immune tolerance in neuromyelitis optica: Part I.

Neurol Neuroimmunol Neuroinflamm 2016 Oct 7;3(5):e276. Epub 2016 Sep 7.

Department of Neurology (L.S.), Stanford University School of Medicine, Palo Alto, CA; Neuroimmunology Unit and Experimental Therapeutics Program (A.B.-O.), Montreal Neurological Institute and Hospital, McGill University, Montreal, Canada; The Guthy-Jackson Charitable Foundation (J.M.B.), San Diego, CA; Department of Gastroenterology (D.B.-R., P.V.), Hospital Clínic, CIBERehd and Center of Neuroimmunology & Inflammatory Bowel Disease, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain; Genentech, Inc. (P.S.C.), South San Francisco, CA; Department of Pathology (M.C.-S.), University of Florida School of Medicine, Gainesville; Opexa Therapeutics (D.H.), The Woodlands, TX; Department of Surgery (J.I.K.), Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Department of Biochemistry (D.M.K.), University of Illinois, Urbana; Neuroimmunology and MS Research (A.L., R.M., S.S.), Department of Neurology, University Hospital Zurich, University Zurich, Switzerland; Forest Landing Court (H.L.W.), Rockville, MD; Ann Romney Center for Neurologic Diseases (S.S.Z.), Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Neurology and Program in Immunology (H.L.W.), University of California, San Francisco School of Medicine; Department of Medicine (S.S.Z.), Divisions of Molecular Medicine & Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles; Harbor-UCLA Medical Center & LABioMed at Harbor-UCLA Medical Center (M.R.Y.), Torrance, CA; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, and Division of Metabolism and Endocrine Diseases, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor (T.J.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000276DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015539PMC
October 2016

Restoring immune tolerance in neuromyelitis optica: Part II.

Neurol Neuroimmunol Neuroinflamm 2016 Oct 7;3(5):e277. Epub 2016 Sep 7.

Neuroimmunology Unit and Experimental Therapeutics Program (A.B.-O.), Montreal Neurological Institute and Hospital, McGill University, Montreal, Canada; Department of Neurology (L.S.), Stanford University School of Medicine, Palo Alto; The Guthy-Jackson Charitable Foundation (J.M.B.), San Diego, CA; Department of Gastroenterology (D.B.-R., P.V.), Hospital Clínic, CIBERehd and Center of Neuroimmunology & Inflammatory Bowel Disease, Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain; Genentech, Inc. (P.S.C.), South San Francisco, CA; Department of Pathology (M.C.-S.), University of Florida School of Medicine, Gainesville; Opexa Therapeutics (D.H.), The Woodlands, TX; Department of Surgery (J.I.K.), Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Department of Biochemistry (D.M.K.), University of Illinois, Urbana; Neuroimmunology and MS Research (A.L., R.M., S.S.), Department of Neurology, University Hospital Zurich, University Zurich, Switzerland; Ann Romney Center for Neurologic Diseases (H.L.W.), Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Neurology and Program in Immunology (S.S.Z.), University of California, San Francisco School of Medicine; Department of Ophthalmology and Visual Sciences (T.J.S.), Kellogg Eye Center, and Division of Metabolism, Endocrine and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor; Department of Medicine (M.R.Y.), Divisions of Molecular Medicine & Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles; and Harbor-UCLA Medical Center & LABioMed at Harbor-UCLA Medical Center (M.R.Y.), Torrance, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000277DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015540PMC
October 2016

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial.

Neurology 2016 Sep 10;87(10):978-87. Epub 2016 Aug 10.

From Neurology (L.K.), Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital Basel, Switzerland; CHU-Hopital Pontchaillou (G.E.), Rennes, France; University of Ottawa (M.S.F.), and the Ottawa Hospital Research Institute, Ottawa, Canada; Hospital Universitari Vall d'Hebron (X.M.), Ps. Vall d'Hebron, Barcelona, Spain; Department of Neurology (H.-P.H., R.S.), Medical Faculty, Heinrich-Heine Universität, Düsseldorf; Technische Universität München (B.H.), Munich, Germany; Central Texas Neurology Consultants (E.J.F.), Round Rock, TX; VU University Medical Center (F.B.), Amsterdam, the Netherlands; Neuroimmunology and Multiple Sclerosis Research (S.S.), Department of Neurology, University Hospital Zurich and University of Zurich, Switzerland; Bayer Pharma AG (A.S., C.P., E.-M.W.), Berlin; Myelo Therapeutics GmbH (D.P.), Berlin; University Hospital of Bonn (C.P.), Germany; and Bayer HealthCare Pharmaceuticals (G.S.), Whippany, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003078DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027814PMC
September 2016

Optimizing treatment success in multiple sclerosis.

J Neurol 2016 Jun 24;263(6):1053-65. Epub 2015 Dec 24.

Department of Neurology, Neuroimmunology and Multiple Sclerosis Research, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-015-7986-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893374PMC
June 2016

Optical Coherence Tomography in Multiple Sclerosis.

Semin Neurol 2016 Apr 26;36(2):177-84. Epub 2016 Apr 26.

Neuroimmunology and Multiple Sclerosis Research, Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0036-1582226DOI Listing
April 2016

Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.

Ann Neurol 2016 Mar 13;79(3):404-18. Epub 2016 Feb 13.

Neuroimmunology and Multiple Sclerosis Research Section, Department of Neurology University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.24574DOI Listing
March 2016

JC polyomavirus mutants escape antibody-mediated neutralization.

Sci Transl Med 2015 Sep 23;7(306):306ra151. Epub 2015 Sep 23.

Lab of Cellular Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://stm.sciencemag.org/lookup/doi/10.1126/scitranslmed.aa
Publisher Site
http://dx.doi.org/10.1126/scitranslmed.aab1720DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290683PMC
September 2015

Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1.

Clin Infect Dis 2014 Dec 11;59(11):1588-92. Epub 2014 Sep 11.

Institute for Neuroimmunology and Clinical MS Research, Center for Molecular Neurobiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Neuroimmunology and Multiple Sclerosis Research, Department of Neurology, University of Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciu682DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650775PMC
December 2014

Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome.

Mult Scler 2013 Dec 23;19(14):1887-95. Epub 2013 May 23.

NeuroCure Clinical Research Center and Experimental and Clinical Research Center, Charité University Medicine Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458513489757DOI Listing
December 2013

JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment.

Ann Neurol 2013 Oct 16;74(4):622-6. Epub 2013 Sep 16.

Neuroimmunology and Multiple Sclerosis Research Section, Department of Neurology, University Hospital Zurich, Zurich; Department of Neurology, University Hospital Zurich, Zurich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.23973DOI Listing
October 2013

Gender differences in circulating levels of neutrophil extracellular traps in serum of multiple sclerosis patients.

J Neuroimmunol 2013 Aug 2;261(1-2):108-19. Epub 2013 Jun 2.

Institute for Neuroimmunology and Clinical MS Research (INiMS), Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Falkenried 94, 20251 Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2013.05.004DOI Listing
August 2013

Placebo cohorts in phase-3 MS treatment trials - predictors for on-trial disease activity 1990-2010 based on a meta-analysis and individual case data.

PLoS One 2012 29;7(11):e50347. Epub 2012 Nov 29.

Institute for Neuroimmunology and Clinical MS Research (inims) and Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0050347PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510222PMC
June 2013

Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations.

Mult Scler 2013 Apr 30;19(4):443-50. Epub 2012 Aug 30.

NeuroCure Clinical Research Centre and Experimental and Clinical Research Centre, Charité-Universitätsmedizin Berlin and Max Delbrueck Centre for Molecular Medicine, Berlin, Germany.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1352458512457844
Publisher Site
http://dx.doi.org/10.1177/1352458512457844DOI Listing
April 2013

Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography.

Mult Scler Int 2012 25;2012:530305. Epub 2012 Jul 25.

NeuroCure Clinical Research Center and Experimental and Clinical Research Center, Charité University Medicine Berlin/Max Delbrück Center for Molecular Medicine, 10117 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/530305DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410317PMC
August 2012

Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis.

Eur J Immunol 2012 Mar 27;42(3):790-8. Epub 2011 Dec 27.

Institute for Neuroimmunology and Clinical MS Research, Center for Molecular Neurobiology Hamburg, University Medical Center-Eppendorf, Hamburg, UKE, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/eji.201142108
Publisher Site
http://dx.doi.org/10.1002/eji.201142108DOI Listing
March 2012

Neutrophils in multiple sclerosis are characterized by a primed phenotype.

J Neuroimmunol 2012 Jan 9;242(1-2):60-71. Epub 2011 Dec 9.

Institute for Neuroimmunology and Clinical MS Research (inims), Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center-Eppendorf, Falkenried 94, 20251 Hamburg (UKE), Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2011.11.009DOI Listing
January 2012

Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome.

Brain 2011 Sep;134(Pt 9):2687-702

Department of Clinical Neuroimmunology and Multiple Sclerosis Research, Neurology Clinic, University Hospital Zürich, University of Zürich, Frauenklinikstrasse 26, 8091 Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awr206DOI Listing
September 2011

Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis.

Lancet Neurol 2010 Sep;9(9):921-32

UCL Institute of Neurology/National Hospital for Neurology and Neurosurgery, Department of Neuroimmunology, Queen Square, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(10)70168-XDOI Listing
September 2010

Abnormal motor cortex plasticity in premanifest and very early manifest Huntington disease.

J Neurol Neurosurg Psychiatry 2010 Mar 13;81(3):267-70. Epub 2009 Oct 13.

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jnnp.2009.171926DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997479PMC
March 2010

Abnormal motor cortex excitability in preclinical and very early Huntington's disease.

Biol Psychiatry 2009 Jun 7;65(11):959-65. Epub 2009 Feb 7.

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopsych.2008.12.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998173PMC
June 2009

Stem cell transplantation in multiple sclerosis.

J Neurol 2008 Dec;255 Suppl 6:43-7

Institute of Neuroimmunology and Multiple Sclerosis Research (INiMS), Center of Molecular Neurobiology, Falkenried 3, 20246 Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-008-6008-8DOI Listing
December 2008

Focal stimulation of the posterior parietal cortex increases the excitability of the ipsilateral motor cortex.

J Neurosci 2007 Jun;27(25):6815-22

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1523/JNEUROSCI.0598-07.2007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6672690PMC
June 2007